Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Atomo Diagnostics Ltd. ( (AU:AT1) ) just unveiled an announcement.
Atomo Diagnostics Ltd. has announced the quotation of 50,983,142 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AT1, effective June 27, 2025. This move is part of a previously announced transaction and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the accessibility of its shares.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. operates in the medical diagnostics industry, focusing on the development and commercialization of rapid diagnostic test devices. The company is known for its innovative point-of-care testing solutions, which are designed to enhance the accessibility and accuracy of diagnostic testing in various healthcare settings.
Average Trading Volume: 610,084
Technical Sentiment Signal: Sell
Current Market Cap: A$10.29M
For an in-depth examination of AT1 stock, go to TipRanks’ Overview page.